Navigation Links
Genomma Lab Announces Its 2010 Earnings Guidance
Date:12/11/2009

MEXICO CITY, Dec. 11 /PRNewswire-FirstCall/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or "the Company") announces today its 2010 earnings guidance.

Genomma Lab expects net sales growth in the range of 42% to 45% for the full year of 2010, excluding possible acquisitions, and an EBITDA margin between 25.0% and 26.0%, from 2009 year-end results which we expect to be above our last issued guidance.

The Company's estimates are based on organic growth in base line products, the full year effect in sales of products launched or acquired during 2009, growth in international operations as well as product line extensions and new brands in existing and new categories.

Company Description

Genomma Lab Internacional, S.A.B. de C.V. is one of the fastest growing pharmaceutical and personal care products companies in Latin America. Genomma Lab develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share. The Company has a sound business model through a unique combination of a new product development process, consumer oriented marketing, a broad retail distribution network and a low-cost, highly flexible supply chain operating model.

    Contact: Oscar Villalobos
    Tel:  +52 (55) 5081- 0000 ext. 4250
    E-mail: inversion@genommalab.com

    In New York: i-advize Corporate Communications, Inc.
    Tel: (212) 406-3695
    E-mail: genomma@i-advize.com

SOURCE Genomma Lab Internacional, S.A.B. de C.V.


'/>"/>
SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Strategic Alliance Between Televisa and Genomma Lab
2. Genomma Lab Internacional Revises 2009 Earnings Guidance
3. Strategic Alliance Between Televisa and Genomma Lab
4. Genomma Lab International Announces Second Quarter 2009 Results
5. Webcast Alert: Genomma Lab Internacional, S.A.B. de C.V. Announces Second Quarter 2009 Results Conference Call
6. Genomma Lab Internacional Acquires Brands Flor de Naranja Sanborns(MR), Teatrical and Henna Egipcia From Grupo Sanborns
7. Genomma Lab Internacional Announces First Quarter 2009 Results
8. Genomma Lab Acquires the Mexican Company Medicinas y Medicamentos Nacionales
9. Genomma Lab Internacional Announces Fourth Quarter and Full Year 2008 Results
10. Webcast Alert: Genomma Lab Announces Fourth Quarter 2008 Earnings Webcast
11. Genomma Lab Announces Updated Fourth Quarter 2008 Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... study published today in Genes & Development ... Sciences Centre,s DNA Replication group, in collaboration with ... intricate mechanisms involved in the enzyme that governs ... sophisticated system using synthetic, chemical and structural biology ... involved in duplicating genetic information embraces DNA through ...
(Date:7/31/2014)... LDM Global ( http://www.ldmglobal.com ) announces the ... simplified and predictable with fixed fees across the board, ... international provider of legal discovery management services for law ... apparent that both the courts and legal counsel alike ... complex pricing structure that plagues the litigation support industry. ...
(Date:7/31/2014)... 2014 The Alaska Center for ... new dentist Dr. Jonathan Oudin, DDS, who will begin ... in Barrow, Alaska, for three years. According to Teresa ... Dr. Oudin to help take on new patients. , ... continue growing and serving the greater Anchorage metro community," ...
(Date:7/31/2014)... 2014 (HealthDay News) -- Transplant surgeons often feel ... for burnout, a new study suggests. Nearly ... reported having a low sense of personal accomplishment ... emotionally exhausted, researchers found. "Burnout is common ... study co-author Dr. Marwan Abouljoud, director of the ...
(Date:7/31/2014)... algorithm aimed to diagnose pediatric patients with suspected ... scans, without affecting diagnostic accuracy, Mayo Clinic Children,s ... published in the journal Surgery . , ... acute abdominal pain in children. Appendicitis occurs when ... CT scans are often used to diagnose acute ...
Breaking Medicine News(10 mins):Health News:Molecular gate that could keep cancer cells locked up 2Health News:LDM Global Announces Predictable Simple Fixed-Fee Pricing 2Health News:Dr. Jonathan Oudin to Join Alaska Center for Dentistry at Wasilla Location 2Health News:Burnout Common Among Transplant Surgeons, Study Reveals 2
... to more false positives, additional work-ups , , THURSDAY, Jan. ... estimating glomerular filtration (eGFR) rates from routine blood work ... with chronic kidney disease, U.S. researchers report. , The ... kidneys over time, and its formula factors in measures ...
... BETHESDA, Md., Jan. 29 /PRNewswire-Asia/ -- Chindex International, Inc.,(Nasdaq: ... of western healthcare,products and services in the People,s Republic ... third quarter 2009 financial results on Monday,February 9, 2009, ... 8:00 am ET that day to discuss financial results. ...
... Meditation technique may help keep discomfort at bay, study ... Zen meditation appears to reduce sensitivity to moderate pain ... "Previous studies had already shown that teaching patients with ... no one had examined how these effects might come ...
... management system designed to meet unique supply management ... Fla., Jan. 29 Omnicell, Inc. (Nasdaq: ... solutions to acute healthcare facilities, and Shands HealthCare ... chain management systems (formerly known as OptiFlex SS) ...
... and FORT LAUDERDALE, Fla., Jan. 29 Houlihan Smith,& ... into Tri-Tech Health, LLC, (Tri-Tech Health) as announced by,Charles ... The,advisory services were led by Houlihan Smith Managing ... , "We have been working ...
... Cholera Outbreak STAMFORD, Conn., Jan. 29 AmeriCares is ... in an effort to stem a deadly cholera outbreak ... outbreak is one of Africa,s deadliest in 15 years ... is at risk. With limited medical resources and dismal ...
Cached Medicine News:Health News:Kidney Function Test May Not Be Cost-Effective 2Health News:Chindex International, Inc. to Report Fiscal Third Quarter 2009 Financial Results 2Health News:The Zen Way to Pain Relief 2Health News:The Zen Way to Pain Relief 3Health News:The Zen Way to Pain Relief 4Health News:Shands HealthCare Increases Operational Efficiency in Surgical Suites With Omnicell Supply Systems 2Health News:Shands HealthCare Increases Operational Efficiency in Surgical Suites With Omnicell Supply Systems 3Health News:Houlihan Smith Arranges Equity Investment Into Tri-Tech Health, LLC 2Health News:AmeriCares Doubles Aid to Zimbabwe 2
(Date:7/31/2014)... July 31, 2014  Decision Resources Group,s ... about by the Affordable Care Act (ACA), ... of pharmaceutical therapies. The ACA altered how ... new regulations and expanded access via government-supported ... health exchanges—state-based marketplaces set up by states ...
(Date:7/31/2014)... LISBON, Portugal , July 31, 2014 ... Cork, Ireland has successfully passed a pre-approval ... The inspection, carried out by the FDA Consumer Safety ... initially planned, started on 21 st July and concluded ... to be compliant with the principles and guidelines of Good ...
(Date:7/31/2014)... announces the list of stocks featured in the Analyst Blog. ... news and events impacting stocks and the financial markets. Stocks ... - Free Report ), Gilead (Nasdaq: GILD - Free ... ), AbbVie (NYSE: ABBV - Free Report ) and ... Today, Zacks is promoting its ,Buy, stock recommendations. Get ...
Breaking Medicine Technology:Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4Successful FDA Inspection at Hovione's API Manufacturing Plant in Cork, Ireland 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6
... Pharmaceutical Corporation (OTC Bulletin Board: PRTT ) announced ... and patents-applications to Grunenthal GmbH, a German specialty pharmaceutical company ... The patent portfolio includes innovative pain drugs that address the ... Protect,s Chief Operating Officer, said, "We are very happy to ...
... NEW YORK, Feb. 9, 2011 Reportlinker.com ... is available in its catalogue: ... and Vulnerable Plaque Treatment 2011 ... report details the responses of a comprehensive ...
Cached Medicine Technology:Protect Pharma Sells Patent Portfolio to Grunenthal GmbH 2Reportlinker Adds Global Physician Survey on Stents, Stent-Grafts and Vulnerable Plaque Treatment 2011 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: